T1	Intervention 0 50	Adjuvant therapy with pegylated interferon alfa-2b
T2	Intervention 58 69	observation
T3	Intervention 280 332	Interferon (IFN) -based adjuvant therapy in melanoma
T4	Intervention 474 541	HRQOL effects of adjuvant pegylated IFN-alpha-2b (PEG-IFN-alpha-2b)
T5	Intervention 549 560	observation
T6	Intervention 685 705	full lymphadenectomy
T7	Intervention 724 745	observation (n = 629)
T8	Intervention 749 945	PEG-IFN-alpha-2b (n = 627): induction 6 micrograms/kg/wk [DOSAGE ERROR CORRECTED] for 8 weeks then maintenance 3 micrograms/kg/wk [DOSAGE ERROR CORRECTED] for an intended total duration of 5 years
T9	Intervention 947 1043	The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire C30
T10	Intervention 1232 1252	PEG-IFN-alpha-2b arm
T11	Intervention 1348 1378	PEG-IFN-alpha-2b treatment arm
T12	Intervention 1397 1408	observation
T13	Intervention 1267 1278	observation
T14	Intervention 1867 1887	PEG-IFN-alpha-2b arm
T15	Intervention 1920 1936	PEG-IFN-alpha-2b
T16	Intervention 2092 2118	EG-IFN-alpha-2b treatment.
